A. Ghosh, MD, DM, C. Naskar, MD, F.- e Roub, MD, DM, and D. Basu, MD, DNB, MAMS, “Review of the adaptations in opioid agonist treatment during the COVID-19 pandemic: Focus on buprenorphine-based treatment”, J of Opioid Management, vol. 17, no. 7, pp. 119–131, Aug. 2021.